Surmodics provides performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures its own proprietary vascular intervention medical device products as well as is engaged in proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, and drug-delivery capabilities; and IVD, which develops, manufactures and sells chemical and biological components for IVD immunoassay tests and molecular diagnostic tests for the diagnostic and biomedical research markets. The SRDX stock yearly return is shown above.
The yearly return on the SRDX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SRDX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|